C3 and chronic kidney disease: A lower risk of CKD and CKD or death was significantly associated with: (i) higher eGFR before biopsy; (ii) a decrease in proteinuria at the six-month follow-up, and (iii) an increase in C3 levels at the six-month follow-up compared with their baseline values at the time of biopsy.